NCT02770118

Brief Summary

The goal of this proposed research is to test the hypothesis that long-term mild sleep restriction (SR), as occurs frequently in adults and adolescents, leads to a positive energy balance and weight gain. Aim 1. To determine the effects of SR, relative to habitual sleep (HS), on food choice and energy intake (EI) in adults at risk of obesity.

  • Hypothesis 1a. EI, assessed by multiple weekly 24-hour recalls, will be greater during a period of SR relative to HS. This will be mostly due to increased fat and carbohydrate intakes.
  • Hypothesis 1b. Neuronal responses to food stimuli, assessed by functional MRI (fMRI) after 6 weeks of SR or HS, will indicate increased activity in networks associated with reward and food valuation (insula, orbitofrontal cortex) during a period of SR relative to HS. These responses will be correlated with intakes of high carbohydrate and high fat foods (hypothesis 1a) and neuropeptide Y (NPY). Moreover, activation of the default mode network (DMN) will be suppressed to a lesser extent after SR compared to HS. Aim 2. To determine the effects of SR, relative to HS, on energy expenditure (EE) via independent and complementary approaches.
  • Hypothesis 2a. EE, assessed by doubly-labeled water (DLW), and physical activity level, monitored daily by actigraphy, will be lower during SR relative to HS.
  • Hypothesis 2b. Brown adipose tissue (BAT), assessed by positron emission tomography and magnetic resonance combined scanner (PET/MR) using 18F-fluorodeoxyglucose (18FDG-PET) and fat fraction (FF) measurement under cold stimulation, will be greater after SR relative to HS. This would suggest higher adaptive thermogenesis after SR compared to HS. BAT activation will also be correlated with NPY. Aim 3. To determine whether SR alters body weight and adiposity relative to HS.
  • Hypothesis 3a. SR will lead to weight gain and increased total adiposity, as assessed using magnetic resonance imaging (MRI), relative to HS.
  • Hypothesis 3b. Increased adiposity after SR will be correlated to an adverse cardio-metabolic risk profile (increased glucose, insulin, triglycerides, leptin, reduced high-density lipoprotein cholesterol and adiponectin) and neuronal responses to food stimuli (Hypothesis 1b), and EE (Hypothesis 2a \& 2b). Failure to stimulate BAT with SR will be associated with greater gain in adiposity.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
4

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jan 2016

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2016

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

February 10, 2016

Completed
3 months until next milestone

First Posted

Study publicly available on registry

May 12, 2016

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2017

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2017

Completed
Last Updated

July 19, 2017

Status Verified

July 1, 2017

Enrollment Period

1.4 years

First QC Date

February 10, 2016

Last Update Submit

July 17, 2017

Conditions

Keywords

sleep restrictionobesitybrown adipose tissue

Outcome Measures

Primary Outcomes (1)

  • Change from baseline Brown adipose tissue (BAT) in 6 weeks

    Assessed by positron emission tomography and magnetic resonance combined scanner (PET/MR) using 18F-fluorodeoxyglucose (18FDG-PET). Fat fraction (FF) measurement under cold stimulation is to be measured.

    6 weeks

Secondary Outcomes (2)

  • Difference in weight from baseline at 6 weeks

    6 weeks

  • Difference in Glucose level from baseline at 6 weeks

    6 weeks

Study Arms (2)

PSR-TSD

EXPERIMENTAL

Partial sleep restriction (PSR) followed by total sleep deprivation (TSD). Experimental procedures will begin with a 3-day period of habitual sleep (HS).

Behavioral: Partial Sleep RestrictionBehavioral: Total Sleep DeprivationBehavioral: Habitual Sleep

TSD-PSR

EXPERIMENTAL

Total sleep deprivation (TSD) followed by partial sleep restriction (PSR). Experimental procedures will begin with a 3-day period of habitual sleep (HS).

Behavioral: Partial Sleep RestrictionBehavioral: Total Sleep DeprivationBehavioral: Habitual Sleep

Interventions

4 hour time in bed (TIB), participants will go to bed 4 hours later than during the HS condition. Wake-up times will be the same. During the in-lab portion of the PSR, meals, fulfilling weight-maintenance energy requirements, will be supplied by the research staff as BOOST shakes.

Also known as: PSR
PSR-TSDTSD-PSR

0 hour time in bed (TIB), participants will remain awake throughout the night. Meals will be provided as BOOST shakes at the same meal.

Also known as: TSD
PSR-TSDTSD-PSR
Habitual SleepBEHAVIORAL

8 hours time in bed (TIB), for 3 nights, with fixed bed and wake times, while at home. During the 3-d HS phase, participants will be provided will BOOST meal replacement shakes in amounts required to achieve weight maintenance.

Also known as: HS
PSR-TSDTSD-PSR

Eligibility Criteria

Age20 Years - 49 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Normal scores on:
  • Pittsburgh Quality of Sleep Questionnaire
  • Epworth Sleepiness Scale
  • Berlin Questionnaire
  • Sleep Disorders Inventory Questionnaire
  • Beck Depression Inventory
  • Composite Scale of Morningness/Eveningness
  • Three Factor Eating Questionnaire
  • Sleep 7-9 hours in bed/night with no daytime nap
  • Age 20-49 years, premenopausal women
  • All racial/ethnic groups
  • Body mass index 25-29.9 kg/m2

You may not qualify if:

  • Smokers (any cigarettes or ex-smoker \<3 years)
  • Neurological, medical or psychiatric disorder, diabetics
  • Eating and/or sleep disorders
  • Contraindications for MRI scanning
  • Travel across time zones within 4 weeks
  • History of drug and alcohol abuse
  • Shift worker (or rotating shift worker)
  • Caffeine intake \>300 mg/d
  • Pregnancy or within 1 y post-partum
  • Heavy equipment operators Commercial long-distance drivers

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

New York Nutrition Obesity Research Center

New York, New York, 10032, United States

Location

MeSH Terms

Conditions

Sleep DeprivationObesity

Condition Hierarchy (Ancestors)

DyssomniasSleep Wake DisordersNervous System DiseasesNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsMental DisordersOverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody Weight

Study Officials

  • Marie-Pierre St-Onge, Ph.D

    Assistant Professor of Nutritional Medicine

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor of Nutritional Medicine, Dept of Medicine Endocrinology

Study Record Dates

First Submitted

February 10, 2016

First Posted

May 12, 2016

Study Start

January 1, 2016

Primary Completion

June 1, 2017

Study Completion

July 1, 2017

Last Updated

July 19, 2017

Record last verified: 2017-07

Data Sharing

IPD Sharing
Will not share

Locations